Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES08 - Sublobar Resection: Oncological Outcome and Advantages
- 14:30 - 15:30
- 8/07/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Stage Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments - Surgery
- Moderators:Masahiro Tsuboi, Monica Casiraghi
-
+
ES08.05 - Are There Benefits of Sublobar Resection Including Lung Function
14:56 - 15:08 | Presenter: Nasser Khaled Altorki
- Abstract
Loading...
-
+
EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
-
+
EP02.04-004 - Time to Surgery After Neoadjuvant Immunotherapy: Not a Day Too Soon
Presenter: Nathan Mynard | Author(s): Timothy McGraw, Benjamin Lee, Jonathan Villena-Vargas, Oliver Chow, Sebron Harrison, Jeffrey Port, Nasser Khaled Altorki- Abstract
Loading...
-
+
PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)
- 08:30 - 10:20
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Plenary
- Track: N/A
- Moderators:Heather Wakelee, Eric Lim
-
+
PL03.06 - Lobar or Sub-lobar Resection for Peripheral Clinical Stage IA = 2 cm Non-small Cell Lung Cancer (NSCLC): Results From an International Randomized Phase III Trial (CALGB 140503 [Alliance])
Presenter: Nasser Khaled Altorki | Author(s): Xiaofei Wang, David Kozono, Colleeen Watt, Rodney Landreneau, Dennis Wigle, Jeffrey Port, David R Jones, Massimo Conti, Ahmad S Ashrafi, Robert Keenan, Thomas Bauer, Leslie J Kohman, Thomas E Stinchcombe, Everett Vokes- Abstract
Loading... -
+
PL03.09 - IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC
Presenter: ENRIQUETA FELIP | Author(s): Heather Wakelee, Nasser Khaled Altorki, Eric Vallieres, Ihor O. Vynnychenko, Andrey Akopov, Alex Martinez-Marti, Antonio Chella, Igor Bondarenko, Sunichi Sugawara, Yun Fan, Hirotsugu Kenmotsu, Yuh-Min Chen, Yu Deng, Fan Wu, Virginia McNally, Elizabeth Bennett, Barbara Gitlitz, Caicun Zhou- Abstract
Loading...
-
+
OA09 - Precision Immunotherapy via Modulation of the Tumor Microenvironment
- 14:45 - 15:45
- 8/08/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Kurt Alex Schalper, Umberto Malapelle
-
+
OA09.05 - Neoadjuvant IL-15-PDL1 Antibody Promotes T cell Memory and Decreases Metastatic Recurrence in Resectable NSCLC
15:07 - 15:17 | Presenter: Jonathan Villena-Vargas | Author(s): Tatiana Delgado Cruz, Geoffrey Markowitz, Arshdeep Singh, Stella Martomo, Jeegar Patel, Nasser Khaled Altorki, Vivek Mittal
- Abstract
Loading...
